| Product Code: ETC13340675 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa mRNA Vaccines and Therapeutics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa mRNA Vaccines and Therapeutics Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa mRNA Vaccines and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Africa mRNA Vaccines and Therapeutics Market - Industry Life Cycle |
3.4 Africa mRNA Vaccines and Therapeutics Market - Porter's Five Forces |
3.5 Africa mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 Africa mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Therapeutic Type, 2021 & 2031F |
3.8 Africa mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Africa mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.10 Africa mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Africa mRNA Vaccines and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa mRNA Vaccines and Therapeutics Market Trends |
6 Africa mRNA Vaccines and Therapeutics Market, 2021 - 2031 |
6.1 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By COVID-19 Vaccine, 2021 - 2031 |
6.1.3 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Influenza Vaccine, 2021 - 2031 |
6.1.4 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Rabies Vaccine, 2021 - 2031 |
6.1.5 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Zika Virus Vaccine, 2020 - 2028 |
6.1.6 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By CMV Vaccine, 2020 - 2028 |
6.2 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031 |
6.2.3 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Personalized Cancer Vaccine, 2021 - 2031 |
6.2.4 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Protein Replacement Therapy, 2021 - 2031 |
6.2.5 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Autoimmune Disease Treatment, 2021 - 2031 |
6.2.6 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By mRNA-Based Drug Delivery, 2020 - 2028 |
6.3 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031 |
6.3.3 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.3.4 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Genetic Disorders, 2021 - 2031 |
6.3.5 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Neurological Disorders, 2021 - 2031 |
6.3.6 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031 |
6.4 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Intramuscular Injection, 2021 - 2031 |
6.4.3 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Subcutaneous Injection, 2021 - 2031 |
6.4.4 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Intradermal Injection, 2020 - 2028 |
6.4.5 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Intravenous Infusion, 2020 - 2028 |
6.4.6 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Oral Delivery, 2020 - 2028 |
6.5 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Hospitals, 2020 - 2028 |
6.5.3 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Clinics, 2020 - 2028 |
6.5.4 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Research Institutes, 2020 - 2028 |
6.5.5 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Biotechnology Firms, 2020 - 2028 |
6.5.6 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Pharmaceutical Companies, 2020 - 2028 |
7 Africa mRNA Vaccines and Therapeutics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.1 South Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.2 Egypt mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.3 Nigeria mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.4 Rest of Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.3 Africa mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Therapeutic Type, 2021 & 2031F |
7.3.1 South Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
7.3.2 Egypt mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
7.3.3 Nigeria mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
7.3.4 Rest of Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
7.4 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.1 South Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.2 Egypt mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.3 Nigeria mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.4 Rest of Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
7.5.1 South Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
7.5.2 Egypt mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
7.5.3 Nigeria mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
7.5.4 Rest of Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
7.6 Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.1 South Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.2 Egypt mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.3 Nigeria mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.4 Rest of Africa mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Africa mRNA Vaccines and Therapeutics Market Key Performance Indicators |
9 Africa mRNA Vaccines and Therapeutics Market - Export/Import By Countries Assessment |
10 Africa mRNA Vaccines and Therapeutics Market - Opportunity Assessment |
10.1 Africa mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
10.3 Africa mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Therapeutic Type, 2021 & 2031F |
10.4 Africa mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
10.5 Africa mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
10.6 Africa mRNA Vaccines and Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
11 Africa mRNA Vaccines and Therapeutics Market - Competitive Landscape |
11.1 Africa mRNA Vaccines and Therapeutics Market Revenue Share, By Companies, 2022 |
11.2 Africa mRNA Vaccines and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here